Rchr
J-GLOBAL ID:200901074911384231   Update date: Feb. 01, 2024

Yanokura Megumi

ヤノクラ メグミ | Yanokura Megumi
Affiliation and department:
Job title: Project Assistant Professor (Non-tenured)/Project Research Associate (Non-tenured)/Project Instructor (Non-tenured)
Research field  (1): Obstetrics and gynecology
Research keywords  (4): 薬剤感受性 ,  細胞周期チェックポイント ,  子宮体癌 ,  DNAメチル化
Research theme for competitive and other funds  (7):
  • 2022 - 2025 Elucidation of implantation inhibition mechanism of endometrial cancer cells using iPS technology
  • 2018 - 2021 Reprogramming study of endometrial cancer cells for restoring fertility
  • 2015 - 2018 Genome-wide DNA methylation analysis in endometrial cancer
  • 2012 - 2015 Application to the development and diagnosis of miRNA therapeutic agent in endometrial cancer
  • 2010 - 2012 endometrial cancer therapy using epigenetically regulated small RNA
Show all
Papers (110):
  • Umene K, Banno K, Kisu I, Yanokura M, Nogami Y, Tsuji K, Masuda K, Ueki A, Kobayashi Y, Yamagami W, et al. Erratum: Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors (Review). Biomedical reports. 2019. 11. 6. 274-274
  • Takeda T, Banno K, Kobayashi Y, Adachi M, Yanokura M, Tominaga E, Kosaki K, Aoki D. Mutations of RAS genes in endometrial polyps. Oncology Reports. 2019. 42. 6. 2303-2308
  • Matoba Y, Kisu I, Sera A, Yanokura M, Banno K, Aoki D. Current status of uterine regenerative medicine for absolute uterine factor infertility (Review). Biomedical Reports. 2019. 10. 2. 79-86
  • Takeda T, Banno K, Yanokura M, Anko M, Kobayashi A, Sera A, Takahashi T, Adachi M, Kobayashi Y, Hayashi S, et al. Synchronous endometrial and ovarian cancer in Lynch syndrome with a MSH2 germline mutation: A case report. Molecular and clinical oncology. 2018. 9. 5. 479-484
  • Takeda T, Banno K, Yanokura M, Takahashi T, Anko M, Sera A, Kunitomi H, Tsuji K, Kobayashi Y, Tominaga E, et al. RAS GENES IS FREQUENTLY MUTATED IN ENDOMETRIAL POLYPS. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2018. 28. 569-569
more...
MISC (23):
  • 矢野倉 恵, 阪埜 浩司, 的場 優介, 辻 浩介, 小林 佑介, 冨永 英一郎, 田中 守, 青木 大輔. ヒト子宮体癌由来培養細胞を用いたReprogrammed-Cancer cellの作成. 日本産科婦人科学会雑誌. 2019. 71. 臨増. S-504
  • AOKI DAISUKE. 子宮内膜癌(類内膜癌)のゲノム解析. 日本臨床 婦人科がん(第2版)-最新の研究動向-. 2018. 76. 増刊号2. 384-389
  • Kunitomi Haruko, Kobayashi Yusuke, Banno Kouji, Okawa Ryuichiro, Masuda Kenta, Yanokura Megumi, Tominaga Eiichiro, Tanaka Mamoru, Aoki Daisuke. ISP-8-4 The characteristics of LAMC1 expression patterns associated with the clinical features of endometrial cancer(Group 8 Endometrial Cancer 3,International Session Poster) :. 2016. 68. 2. 500-500
  • 大川 隆一朗, 阪埜 浩司, 矢野倉 恵, 増田 健太, 安達 将隆, 野上 侑哉, 國富 晴子, 冨永 英一郎, 田中 守, 青木 大輔. P2-5-6 子宮体部明細胞癌に対するARID1Aタンパクの発現解析 : 卵巣明細胞癌との比較(Group5 子宮体部腫瘍・基礎,一般演題,公益社団法人日本産科婦人科学会第68回学術講演会). 日本産科婦人科學會雜誌. 2016. 68. 2. 631-631
  • Takeda Takashi, Banno Kouji, Yanokura Megumi, Iijima Moito, Iida Miho, Adachi Masataka, Masuda Kenta, Kobayashi Yusuke, Tominaga Eiichiro, Tanaka Mamoru, et al. IS-AC-2-1 Methylation analysis of DNA mismatch repair genes using DNA derived from peripheral blood of patients with endometrial cancer : epimutation in endometrial carcinogenesis(Group 2 Oncology 2,International Session Award Candidate) :. 2016. 68. 2. 457-457
more...
Lectures and oral presentations  (58):
  • ヒト子宮体癌由来培養細胞を用いたReprogrammed-Cancer cellの作成
    (日本産科婦人科学会雑誌 2019)
  • 【婦人科がん(第2版)-最新の研究動向-】 子宮体がん 子宮体癌の発生 子宮内膜癌(類内膜癌)のゲノム解析
    (日本臨床 2018)
  • CIMP-H子宮体癌患者の末梢血を利用したTargeted bisulfite sequencing
    (日本癌学会総会記事 2016)
  • 子宮体部明細胞癌に対するARID1Aタンパクの発現解析 卵巣明細胞癌との比較
    (日本産科婦人科学会雑誌 2016)
  • メトホルミンとジエノゲストの併用はDNAのメチル化を変化させ子宮体癌細胞の増殖を抑制させる
    (日本産科婦人科学会雑誌 2015)
more...
Education (2):
  • 2013 - 2017 筑波大学 生命環境科学 生物科学
  • 2006 - Keio University Graduate School, Division of Medicine 医科学
Professional career (2):
  • 修士(医科学) (Keio University)
  • 博士(理学) (筑波大学大学院)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page